Thomas Jennison
Adelphi Group (United Kingdom)(GB)
Publications by Year
Research Areas
Chronic Obstructive Pulmonary Disease (COPD) Research, Asthma and respiratory diseases, Inhalation and Respiratory Drug Delivery, Diabetes Treatment and Management, Diabetes Management and Research
Most-Cited Works
- → Benefit of Prompt Vs Delayed Initiation of Triple Therapy Following an Exacerbation in Patients with COPD in Japan: A Retrospective Cohort Study(2023)11 cited
- → Comparative adherence and persistence of single-inhaler and multiple-inhaler triple therapies among patients with chronic obstructive pulmonary disease in Japan: a retrospective cohort study(2024)7 cited
- → Effectiveness of Switching from Multiple-Inhaler to Once-Daily Single-Inhaler Triple Therapy in Patients with COPD in a Real-World Setting in Japan(2025)3 cited
- → Achievement of HbA1c and weight targets in adults with type 2 diabetes on once weekly injectable glucagon‐like peptide‐1 receptor agonist therapy in UK primary care: A retrospective, real‐world study(2025)3 cited
- → Adherence to single and multiple inhaler triple therapies among patients with COPD in the real world in Japan(2023)1 cited
- → Author response for "Achievement of <scp>HbA1c</scp> and weight targets in adults with type 2 diabetes on once weekly injectable glucagon‐like peptide‐1 receptor agonist therapy in <scp>UK</scp> primary care: A retrospective, real‐world study"(2024)